343 related articles for article (PubMed ID: 31899311)
1. SUR1-TRPM4 channels, not K
Woo SK; Tsymbalyuk N; Tsymbalyuk O; Ivanova S; Gerzanich V; Simard JM
Neurosci Lett; 2020 Jan; 718():134729. PubMed ID: 31899311
[TBL] [Abstract][Full Text] [Related]
2. Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date.
King ZA; Sheth KN; Kimberly WT; Simard JM
Drug Des Devel Ther; 2018; 12():2539-2552. PubMed ID: 30147301
[TBL] [Abstract][Full Text] [Related]
3. Sulfonylurea Receptor 1, Transient Receptor Potential Cation Channel Subfamily M Member 4, and KIR6.2:Role in Hemorrhagic Progression of Contusion.
Gerzanich V; Stokum JA; Ivanova S; Woo SK; Tsymbalyuk O; Sharma A; Akkentli F; Imran Z; Aarabi B; Sahuquillo J; Simard JM
J Neurotrauma; 2019 Apr; 36(7):1060-1079. PubMed ID: 30160201
[TBL] [Abstract][Full Text] [Related]
4. SUR1-TRPM4 and AQP4 form a heteromultimeric complex that amplifies ion/water osmotic coupling and drives astrocyte swelling.
Stokum JA; Kwon MS; Woo SK; Tsymbalyuk O; Vennekens R; Gerzanich V; Simard JM
Glia; 2018 Jan; 66(1):108-125. PubMed ID: 28906027
[TBL] [Abstract][Full Text] [Related]
5. Glimepiride and glibenclamide have comparable efficacy in treating acute ischemic stroke in mice.
Wang X; Chang Y; He Y; Lyu C; Li H; Zhu J; Liu K; Hu Y; Huang K; Pan S
Neuropharmacology; 2020 Jan; 162():107845. PubMed ID: 31704276
[TBL] [Abstract][Full Text] [Related]
6. On potential interactions between non-selective cation channel TRPM4 and sulfonylurea receptor SUR1.
Sala-Rabanal M; Wang S; Nichols CG
J Biol Chem; 2012 Mar; 287(12):8746-56. PubMed ID: 22291026
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis.
Li CG; Cui WY; Wang H
Acta Pharmacol Sin; 2016 Jan; 37(1):134-42. PubMed ID: 26725741
[TBL] [Abstract][Full Text] [Related]
8. The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel.
Woo SK; Kwon MS; Ivanov A; Gerzanich V; Simard JM
J Biol Chem; 2013 Feb; 288(5):3655-67. PubMed ID: 23255597
[TBL] [Abstract][Full Text] [Related]
9. Role of the C-terminus of SUR in the differential regulation of β-cell and cardiac K
Vedovato N; Rorsman O; Hennis K; Ashcroft FM; Proks P
J Physiol; 2018 Dec; 596(24):6205-6217. PubMed ID: 30179258
[TBL] [Abstract][Full Text] [Related]
10. Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis.
Makar TK; Gerzanich V; Nimmagadda VK; Jain R; Lam K; Mubariz F; Trisler D; Ivanova S; Woo SK; Kwon MS; Bryan J; Bever CT; Simard JM
J Neuroinflammation; 2015 Nov; 12():210. PubMed ID: 26581714
[TBL] [Abstract][Full Text] [Related]
11. SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells.
Gerzanich V; Kwon MS; Woo SK; Ivanov A; Simard JM
PLoS One; 2018; 13(4):e0195526. PubMed ID: 29617457
[TBL] [Abstract][Full Text] [Related]
12. Effects of ZD0947, a novel and potent ATP-sensitive K
Mori K; Yamashita Y; Teramoto N
Eur J Pharmacol; 2016 Nov; 791():773-779. PubMed ID: 27693800
[TBL] [Abstract][Full Text] [Related]
13. Sur1-Trpm4 Cation Channel Expression in Human Cerebral Infarcts.
Mehta RI; Tosun C; Ivanova S; Tsymbalyuk N; Famakin BM; Kwon MS; Castellani RJ; Gerzanich V; Simard JM
J Neuropathol Exp Neurol; 2015 Aug; 74(8):835-49. PubMed ID: 26172285
[TBL] [Abstract][Full Text] [Related]
14. KATP channel subunits in rat dorsal root ganglia: alterations by painful axotomy.
Zoga V; Kawano T; Liang MY; Bienengraeber M; Weihrauch D; McCallum B; Gemes G; Hogan Q; Sarantopoulos C
Mol Pain; 2010 Jan; 6():6. PubMed ID: 20102598
[TBL] [Abstract][Full Text] [Related]
15. Variants in genes encoding the SUR1-TRPM4 non-selective cation channel and sudden infant death syndrome (SIDS): potentially increased risk for cerebral edema.
Qu D; Schürmann P; Rothämel T; Dörk T; Klintschar M
Int J Legal Med; 2022 Jul; 136(4):1113-1120. PubMed ID: 35474489
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol reduces cerebral edema through inhibition of de novo SUR1 expression induced after focal ischemia.
Alquisiras-Burgos I; Ortiz-Plata A; Franco-Pérez J; Millán A; Aguilera P
Exp Neurol; 2020 Aug; 330():113353. PubMed ID: 32380020
[TBL] [Abstract][Full Text] [Related]
17. Role of Glibenclamide in Brain Injury After Intracerebral Hemorrhage.
Jiang B; Li L; Chen Q; Tao Y; Yang L; Zhang B; Zhang JH; Feng H; Chen Z; Tang J; Zhu G
Transl Stroke Res; 2017 Apr; 8(2):183-193. PubMed ID: 27807801
[TBL] [Abstract][Full Text] [Related]
18. ATP-sensitive Potassium Channel Subunits in Neuroinflammation: Novel Drug Targets in Neurodegenerative Disorders.
Maqoud F; Scala R; Hoxha M; Zappacosta B; Tricarico D
CNS Neurol Disord Drug Targets; 2022; 21(2):130-149. PubMed ID: 33463481
[TBL] [Abstract][Full Text] [Related]
19. ATP binding without hydrolysis switches sulfonylurea receptor 1 (SUR1) to outward-facing conformations that activate K
Sikimic J; McMillen TS; Bleile C; Dastvan F; Quast U; Krippeit-Drews P; Drews G; Bryan J
J Biol Chem; 2019 Mar; 294(10):3707-3719. PubMed ID: 30587573
[TBL] [Abstract][Full Text] [Related]
20. Glibenclamide for the treatment of ischemic and hemorrhagic stroke.
Caffes N; Kurland DB; Gerzanich V; Simard JM
Int J Mol Sci; 2015 Mar; 16(3):4973-84. PubMed ID: 25749474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
